| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2011-07-29 | safinamide | Parkinson\'s disease |
3 | Merck Serono, a Merck KGaA company (Germany) Newron Pharmaceuticals (Italy) | Neurodegenerative diseases - CNS diseases |
| 2011-07-29 | NGR-hTNF | platinum-resistant/refractory ovarian cancer | 2 | MolMed (Italy) | Cancer Oncology |
| 2011-07-28 | OBI-1 (intravenous recombinant porcine factor VIII product - rpFVIII) | treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia | 3 | Ipsen (France) Inspiration Biopharmaceuticals (USA) | Hematological diseases - Genetic diseases |
| 2011-07-26 | recombinant factor VIII Fc fusion protein (rFVIIIFc) | Hemophilia A |
1-2a | BiogenIdec (USA) Swedish Orphan Biovitrum (Sweden) | Hematological diseases |
| 2011-07-25 | Xarelto® (rivaroxaban) | non-valvular atrial fibrillation | 3 | Bayer HealthCare (Germany) | Cardiovascular diseases |
| 2011-07-25 | EV-077 | complications of diabetes | preclinical | Evolva (Switzerland) | Metabolic diseases |
| 2011-07-24 | Neu-P11 (piromelatine) | insomnia | 1b | Neurim Pharmaceuticals (Israel - Switzerland) | CNS diseases |
| 2011-07-20 | GLPG0492 | cachexia |
1 | Galapagos (Belgium) | Genetic diseases - Neuromuscular diseases - Rare diseases |
| 2011-07-19 | EHT Dx14 | breast cancer | Exonhit (France) | Cancer Oncology | |
| 2011-07-19 | Actemra® (tocilizumab) | rheumatoid arthritis | 3 | Chugai (Japan) Roche (Switzerland) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2011-07-19 | HIV-neutralizing antibody 2G12 | HIV-AIDS | 1 | Pharma-Planta (EU Sixth Framework Integrated Project that was launched in 2004, involving 30 academic and industrial partners) | Infectious diseases |
| 2011-07-18 | AIC316 | genital herpes | 2 | AiCuris (Germany) | Infectious diseases |
| 2011-07-18 | IHD-Amy blood test | Alzheimer's disease | Innovative Health Diagnostics (France) | Neurodegenerative diseases | |
| 2011-07-15 | EV-077 | complications of diabetes | 1 | Evolva (Switzerland) | Metabolic diseases |
| 2011-07-14 | SBG Soluble Beta-Glucan | neuroblastoma | 1-2 | Biotec Pharmacon (Norway) | Cancer Oncology |
| 2011-07-13 | Aviscumine (CY503) | refractory metastatic melanoma (stage IV) | 2 | Cytavis Biopharma (Germany) | Cancer Oncology |
| 2011-07-12 | sarilumab | rheumatoid arthritis |
2b | Sanofi (France) Regeneron Pharmaceutical (USA) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2011-07-12 | sarilumab | ankylosing spondylitis |
2b | Sanofi (France) Regeneron Pharmaceutical (USA) | Autoimmune diseases |
| 2011-07-12 | GFT505 | 2a | Genfit (France) | Metabolic diseases - Cardiovascular diseases | |
| 2011-07-11 | Lemtrada® (alemtuzumab) | multiple sclerosis |
3 | Sanofi (France) Genzyme (USA - MA) | Autoimmune diseases - Neurodegenerative diseases |
